Verition Fund Management
KYNB

Verition Fund Management’s Kyntra Bio KYNB Stock Holding History

Verition Fund Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,800
Closed -$84.8K – 3293
2024
Q2 		$84.8K Buy
+3,800
New +$117K ﹤0.01% 2748
2023
Q3 		– Sell
-564
Closed -$38.1K – 2450
2023
Q2 		$38.1K Buy
+564
New +$233K ﹤0.01% 2050
2022
Q1 		– Sell
-13,764
Closed -$4.85M – 2819
2021
Q4 		$4.85M Buy
13,764
+13,056
+1,844% +$4.07M 0.04% 374
2021
Q3 		$181K Buy
+708
New +$251K ﹤0.01% 1631
2020
Q4 		– Sell
-990
Closed -$1.04M – 1191
2020
Q3 		$1.02M Sell
990
-538
-35% -$579K 0.02% 377
2020
Q2 		$1.55M Buy
+1,528
New +$1.42M 0.05% 283
2020
Q1 		– Sell
-1,572
Closed -$1.69M – 763
2019
Q4 		$1.69M Buy
+1,572
New +$1.6M 0.03% 306
2019
Q3 		– Sell
-1,644
Closed -$1.81M – 1139
2019
Q2 		$1.86M Buy
+1,644
New +$1.8M 0.05% 254
2017
Q4 		– Sell
-150
Closed -$202K – 978
2017
Q3 		$202K Buy
+150
New +$158K 0.02% 1074

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Verition Fund Management's KYNB Position: Q3 2024 in Review

Verition Fund Management sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 3,800 shares — an estimated $84.8K sold.

Verition Fund Management first reported a position in KYNB in Q3 2017 and held it in 9 quarters. The position peaked at $4.85M in Q4 2021. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Verition Fund Management reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 3,800 Kyntra Bio shares in Q3 2024, an estimated $84.8K.
  • Verition Fund Management first reported a position in Kyntra Bio in Q3 2017 and held it in 9 quarters.
  • Verition Fund Management's Kyntra Bio position peaked at $4.85M in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.